Autres langues Otsuka Corporation

Actions

4768

JP3188200004

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 20/05/2024			Varia. 5j.	Varia. 1 janv.
2 916 ^JPY	+0,26 %		-1,39 %	+0,31 %

30/04	Le bénéfice attribuable d'Otsuka Holdings bondit de 26% au premier trimestre	MT
09/04	H. Lundbeck et Otsuka Pharmaceutical cherchent à obtenir le feu vert de la FDA pour une thérapie combinée contre le SSPT	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Otsuka Holdings' Attributable Profit Jumps 26% in Q1	30/04
Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation	29/04
H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	09/04
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	29/03
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	27/03
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18/03
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	26/02
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02
MÄRKTE ASIEN/Schwach - Zinssenkungshoffnungen schwinden	14/02
MÄRKTE ASIEN/Leichter nach US-Dämpfer für Zinssenkungshoffnungen	14/02
Otsuka Holdings Lowers 2023 Profit Outlook	13/02
Japan's Nikkei cruises to 34-year peak, briefly breaching 38,000 range	13/02
Japan's Nikkei soars to 34-year high on chip shares, earnings	13/02
Phase 3 Trial for Otsuka's Alzheimer's-related Agitation Treatment Fails to Meet Primary Endpoint	13/02
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	13/02
Otsuka Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/02
Ionis Pharmaceuticals Says Potential Angioedema Treatment Met Primary Endpoint of Phase 3 Study	22/01
Ionis Pharmaceuticals Signs Europe Licensing Deal With Otsuka for Donidalorsen in Hereditary Angioedema	18/12
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026	18/12
Otsuka Unit Buys New York-Based Provider of Women Health Products	05/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Otsuka Corporation

Actions

4768

JP3188200004

Autres langues

Filtres